CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-14 | Lane Michael Executive Vice President | Option exercise · Restricted Stock Unit | −181 | 0 | ||
| 2024-02-14 | Lane Michael Executive Vice President | Option exercise · Restricted Stock Unit | −173 | 0 | ||
| 2024-02-14 | Lane Michael Executive Vice President | Option exercise · Restricted Stock Unit | −161 | 160 | ||
| 2024-02-14 | Lane Michael Executive Vice President | Option exercise · Restricted Stock Unit | −204 | 408 | ||
| 2024-02-14 | Lane Michael Executive Vice President | Option exercise · Restricted Stock Unit | −220 | 660 | ||
| 2024-02-14 | Johnson Michael Perkins EVP and CHRO | Option exercise | +176 | 243.34 | ||
| 2024-02-14 | Johnson Michael Perkins EVP and CHRO | Shares withheld for taxes | −60 | $560.56 | $34K | 183.34 |
| 2024-02-14 | Johnson Michael Perkins EVP and CHRO | Grant or award · Non-Qualified Stock Option (right-to-buy) | +3,132 | 3,132 | ||
| 2024-02-14 | Johnson Michael Perkins EVP and CHRO | Grant or award · Incentive Stock Option (right-to-buy) | +178 | 178 | ||
| 2024-02-14 | Johnson Michael Perkins EVP and CHRO | Grant or award · Restricted Stock Unit | +714 | 714 | ||
| 2024-02-14 | Johnson Michael Perkins EVP and CHRO | Option exercise · Restricted Stock Unit | −176 | 528 | ||
| 2024-02-14 | Hunt Nimrata Executive Vice President | Option exercise | +126 | 11,193.23 | ||
| 2024-02-14 | Hunt Nimrata Executive Vice President | Option exercise | +173 | 11,366.23 | ||
| 2024-02-14 | Hunt Nimrata Executive Vice President | Option exercise | +161 | 11,527.23 | ||
| 2024-02-14 | Hunt Nimrata Executive Vice President | Option exercise | +204 | 11,731.23 | ||
| 2024-02-14 | Hunt Nimrata Executive Vice President | Grant or award | +208 | 11,939.23 | ||
| 2024-02-14 | Hunt Nimrata Executive Vice President | Shares withheld for taxes | −263 | $560.56 | $147K | 11,676.23 |
| 2024-02-14 | Hunt Nimrata Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +5,407 | 5,407 | ||
| 2024-02-14 | Hunt Nimrata Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +178 | 178 | ||
| 2024-02-14 | Hunt Nimrata Executive Vice President | Grant or award · Restricted Stock Unit | +1,204 | 1,204 |
Page 34 of 52 · 1,036 trades